Expression of the calcium-binding protein S100P is regulated by bone morphogenetic protein in pancreatic duct epithelial cell lines

Cancer Science

Volumn 100, Issue 1, 2009, Pages 103-110

  Hamada, Shin ^a   Satoh, Kennichi ^a   Hirota, Morihisa ^a   Fujibuchi, Wataru ^b   Kanno, Atsushi ^a   Umino, Jun ^a   Ito, Hiromichi ^a   Satoh, Akihiko ^a   Kikuta, Kazuhiro ^a   Kume, Kiyoshi ^a   Masamune, Atsushi ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; CALCIUM BINDING PROTEIN; CALCIUM BINDING PROTEIN S100P; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; EPITHELIUM CELL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NULL CELL; PANCREAS CANCER; PANCREAS DUCT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

BONE MORPHOGENETIC PROTEIN 4; CALCIUM-BINDING PROTEINS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; SMAD4 PROTEIN;

EID: 58149313658     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00993.x     Document Type: Article

References (31)

1. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-58.
2. Hamada S, Satoh K, Hirota M et al. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line. J Cell Physiol 2007; 213: 768-74.
3. Kretzschmar M, Liu F, Hata A, Doody J, Massagué J. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 1997; 11: 984-95.
4. Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, Yoneda T. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 1998; 273: 1872-9.
5. Kawai S, Faucheu C, Gallea S et al. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity. Biochem Biophys Res Commun 2000; 271: 682-7.
6. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 1996; 383: 832-6.
7. Hu MC, Wasserman D, Hartwig S, Rosenblum ND. p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. J Biol Chem 2004; 279: 12051-9.
8. Satoh K, Hamada S, Kimura K et al. Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells. Am J Pathol 2008; 172: 926-39.
9. Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA, Tsao MS. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol 1996; 148: 1763-70.
10. Schafer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: Rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 1995; 25: 638-43.
11. Arumugam T, Simeone DM, Schmidt AM, Logsdon CD. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 2004; 279: 5059-65.
12. Arumugam T, Simeone DM, Van Golen K, Logsdon CD. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 2005; 11: 5356-64.
13. Whiteman HJ, Weeks ME, Dowen SE et al. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 2007; 67: 8633-42.
14. Ohuchida K, Mizumoto K, Egami T et al. S100P is an early developmental marker of pancreatic carcinogenesis. Clin Cancer Res 2006; 12: 5411-16.
15. Workman C, Jensen LJ, Jarmer H et al. A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol 2002: 3: research 0048.1. -16.
16. Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. J Mol Diagn 2003; 5: 73-81.
17. Suzuki T, Miki Y, Nakata T et al. Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma. J Steroid Biochem Mol Biol 2003; 86: 449-54.
18. Han S, Roman J. COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals. Lung Cancer 2006; 51: 283-96.
19. Hamada S, Watanabe K, Hirota M et al. β-Catenin/TCF/LEF regulate expression of the short form human Cripto-1. Biochem Biophys Res Commun 2007; 355: 240-4.
20. Cartharius K, Frech K, Grote K et al. MatInspector and beyond: Promoter analysis based on transcription factor binding sites. Bioinformatics 2005; 21: 2933-42.
21. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A. ID genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 1999; 274: 19838-45.
22. Ku M, Howard S, Ni W, Lagna G, Hata A. OAZ regulates bone morphogenetic protein signaling through Smad6 activation. J Biol Chem 2006; 281: 5277-87.
23. Haudenschild DR, Palmer SM, Moseley TA, You Z, Reddi AH. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer. Cancer Res 2004; 64: 8276-84.
24. Liu C, Yao J, de Belle I, Huang RP, Adamson E, Mercola D. The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-β1, fibronectin, and plasminogen activator inhibitor-1. J Biol Chem 1999; 274: 4400-11.
25. Schutte M, Hruban RH, Hedrick L et al. DPC4 gene in various tumor types. Cancer Res 1996; 56: 2527-30.
26. Qian J, Niu J, Li M, Chiao PJ, Tsao MS. In.vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Cancer Res 2005; 65: 5045-53.
27. Fink SP, Mikkola D, Willson JK, Markowitz S. TGF-β-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines. Oncogene 2003; 22: 1317-23.
28. Chao A, Wang TH, Lee YS et al. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer 2006; 119: 91-8.
29. Wang G, Platt-Higgins A, Carroll J et al. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 2006; 66: 1199-207.
30. 2+ regulated ezrin-S100P interaction and its role in tumor cell migration. J Biol Chem Epub 2008 Aug 20.
31. Ko SO, Chung IH, Xu X et al. Smad4 is required to regulate the fate of cranial neural crest cells. Dev Biol 2007; 312: 435-47.